Skip to content

The effect of lifestyle intervention on primary and secondary prevention of type 2 diabetes in the elderly--Cluster randomized controlled study

Establishment and Application of Suitable Diabetes Prevention and Control Technology and Management Platform

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028672
Enrollment
Unknown
Registered
2019-12-30
Start date
2019-10-09
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Experimental group:lifestyle intervention
Control group:Routine health education

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Screening research: 1) aged >=65 years; 2) BMI >=24 kg/m2; 3) functional independence. 2. Primary prevention: pre-diabetes: impaired glucose tolerance (blood glucose 7.8-11.0mmol/L after 2 hours of OGTT) 3. Secondary prevention: new type 2 diabetes (fasting blood glucose >=7 mmol/L or OGTT 2h blood glucose> 11.1 mmol/L).

Exclusion criteria

Exclusion criteria: 1) No medical system data; 2) Clinical evidence of vestibular dysfunction; 3) Orthostatic hypotension; 4) History of plantar ulcer; 5) Participating in dietary exercise interventions and weight loss programs; 6) No willingness to follow up; 7) Patients with a history of severe cognitive impairment or central nervous system dysfunction, such as hemiplegia, myelopathy, and brain ataxia; 8) Obvious musculoskeletal deformities such as amputation, scoliosis, abnormal movement or arthritic patients with limited pain during exercise; 9) Diseases that seriously affect the quality of life: malignant tumors, taking antipsychotic drugs, oral steroids, stage 4 renal impairment or receiving dialysis treatment, NYHA stage IV heart failure, history of clinical evidence of severe cardiovascular disease.

Design outcomes

Primary

MeasureTime frame
Fasting plasma glucose;OGTT 2h glucose;

Secondary

MeasureTime frame
Height;Weight;Waist;Hips;Blood pressure;Fasting lipid;Liver and kidney function;Food frequency;Exercise frequency;Health Utility;

Countries

China

Contacts

Public ContactTian Limin

Gansu Provincial Hospital

272842435@qq.com+86 15293184257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026